Home Europe European Commission Commission Implementing Regulation (EU) 2024/1734 of 21 June...
Date: 24-Jun-2024 Category: Not Applicable State: Union Government Country: Europe

Commission Implementing Regulation (EU) 2024/1734 of 21 June 2024 amending Implementing Regulation (EU) No 686/2012 as regards allocation to Member States, for the purposes of the renewal procedure, of the evaluation of the active substance deltamethrin

Issued by European Commission · Directorate-General for Health and Food Safety

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

What it means

  • Commission Implementing Regulation (EU) 2024/1734 amends Implementing Regulation (EU) No 686/2012 regarding the allocation of the evaluation of the active substance deltamethrin to Member States for the renewal procedure.
  • The amendment assigns Sweden as a co-rapporteur Member State for the renewal of the approval of deltamethrin, alongside Austria (AT) which is the Rapporteur Member State.

Key Changes

  • Sweden is now a co-rapporteur Member State for the evaluation of deltamethrin.
  • The original allocation under Implementing Regulation (EU) No 686/2012 is modified to reflect this change.
  • This change is due to the need for additional information requested by the Authority under Article 13(3a) of Commission Implementing Regulation (EU) No 844/2012.
  • The change aims to facilitate coherence and efficiency in the evaluation under Regulation (EC) No 1107/2009 and Regulation (EU) No 528/2012, as Sweden is already the evaluating competent authority for the renewal of deltamethrin under Regulation (EU) No 528/2012.

Impact Analysis

Stakeholders

  • General Public: The public has an interest in the safety and regulation of plant protection products.

Suggested Action Items

  • All Stakeholders: Stay informed about the outcomes of the evaluation and any potential changes to the approval status of deltamethrin.

Key Entities Referenced

Commission Implementing Regulation (EU) 2024/1734: The current regulation amending Implementing Regulation (EU) No 686/2012. Commission Implementing Regulation (EU) No 686/2012: Regulation allocating the evaluation of active substances to Member States for renewal procedures. This regulation is amended by the current regulation. Regulation (EC) No 1107/2009: Regulation concerning the placing of plant protection products on the market. Commission Implementing Regulation (EU) No 844/2012: Regulation setting out the provisions necessary for the implementation of the renewal procedure for active substances. Regulation (EU) No 528/2012: Regulation concerning the making available on the market and use of biocidal products. Deltamethrin: The active substance being evaluated for renewal of approval. Austria (AT): The Rapporteur Member State for Deltamethrin. Sweden (SE): The Co-rapporteur Member State for Deltamethrin.
Official Source Record View Original Source →
See Full Document Text
Official Journal EN of the European Union L series 2024/1734 24.6.2024 COMMISSION IMPLEMENTING REGULATION (EU) 2024/1734 of 21 June 2024 amending Implementing Regulation (EU) No 686/2012 as regards allocation to Member States, for the purposes of the renewal procedure, of the evaluation of the active substance deltamethrin (Text with EEA relevance) THE EUROPEAN COMMISSION, Having regard to the Treaty on the Functioning of the European Union, Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC(1), and in particular Article 19 thereof, Whereas: (1) Commission Implementing Regulation (EU) No 686/2012(2) allocates the evaluation of the active substances deltamethrin, diflufenican, epoxiconazole, fluoxastrobin, prothioconazole and tebuconazole for the purposes of the renewal procedures to respective Member States, naming for each active substance a rapporteur and a co-rapporteur. (2) Commission Implementing Regulation (EU) 2019/150(3) changes the allocation of the evaluation of those active substances to respectively other rapporteur Member States, following the notification submitted by the United Kingdom of its intention to withdraw from the Union pursuant to Article 50 of the Treaty on European Union. (3) The allocation is based on the consideration that the evaluation of the active substances concerned is at an advanced stage and the work to be carried out is expected to be minor. Therefore, no co-rapporteur Member State is allocated for that evaluation. (4) However, on 28 August 2023, the Authority requested, pursuant to Article 13(3a) of Commission Implementing Regulation (EU) No 844/2012(4), additional information for the active substance deltamethrin, for the purposes of assessment of the approval criteria set out in points 3.6.5 and 3.8.2 of Annex II to Regulation (EC) No 1107/2009. (5) Since Sweden is the evaluating competent authority for the renewal of the approval of the active substance deltamethrin in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council(5)it is considered appropriate, with a view to facilitating coherence and efficiency in the evaluation under Regulation (EC) No 1107/2009 and Regulation (EU) No 528/2012, to allocate Sweden as a co-rapporteur Member State for the purposes of the renewal of the approval of deltamethrin. (6) Implementing Regulation (EU) No 686/2012 should therefore be amended accordingly. (1) OJ L 309, 24.11.2009, p. 1, ELI: http://data.europa.eu/eli/reg/2009/1107/oj. (2) Commission Implementing Regulation (EU) No 686/2012 of 26 July 2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of active substances (OJ L 200, 27.7.2012, p 5, ELI: http://data.europa.eu/eli/reg_impl/2012/686/ 2023-10-08). (3) Commission Implementing Regulation (EU) 2019/150 of 30 January 2019 amending Implementing Regulation (EU) No 686/2012 as regards the rapporteur Member State for the evaluation of the following active substances contained in plant protection products: deltamethrin, diflufenican, epoxiconazole, fluoxastrobin, prothioconazole and tebuconazole (OJ L 27, 31.1.2019, p. 23, ELI: http://data.europa.eu/eli/reg_impl/2019/150/oj). (4) Commission Implementing Regulation (EU) No 844/2012 of 18 September 2012 setting out the provisions necessary for the implementation of the renewal procedure for active substances, as provided for in Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (OJ L 252, 19.9.2012, p. 26, ELI: http://data.europa.eu/eli/reg_impl/2012/844/2020-02-13). (5) Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (OJ L 167, 27.6.2012, p. 1, ELI: http://data.europa.eu/eli/reg/2012/528/2022-04-15). ELI: http://data.europa.eu/eli/reg_impl/2024/1734/oj 1/2EN OJ L, 24.6.2024 (7) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed, HAS ADOPTED THIS REGULATION: Article 1 In Part A of the Annex to Implementing Regulation (EU) No 686/2012 the entry for Deltamethrin is replaced by the following: Rapporteur Member Co-rapporteur Member Active substance State State ‘Deltamethrin AT SE’ Article 2 This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union. This Regulation shall be binding in its entirety and directly applicable in all Member States. Done at Brussels, 21 June 2024. For the Commission The President Ursula VON DER LEYEN 2/2 ELI: http://data.europa.eu/eli/reg_impl/2024/1734/oj

Continue your research